866-997-4948(US-Canada Toll Free)

Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 101 Pages

Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Human Papillomavirus (HPV) Associated Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Human Papillomavirus (HPV) Associated Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101

List of Tables
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Human Papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Human Papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 99

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *